Literature DB >> 19534534

Recent advances in the development of polyamine analogues as antitumor agents.

Robert A Casero1, Patrick M Woster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19534534      PMCID: PMC2762202          DOI: 10.1021/jm900187v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  178 in total

1.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

2.  E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.

Authors:  P G Corn; B D Smith; E S Ruckdeschel; D Douglas; S B Baylin; J G Herman
Journal:  Clin Cancer Res       Date:  2000-11       Impact factor: 12.531

Review 3.  Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment.

Authors:  N E Davidson; H A Hahm; D E McCloskey; P M Woster; R A Casero
Journal:  Endocr Relat Cancer       Date:  1999-03       Impact factor: 5.678

4.  Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines.

Authors:  C W Porter; B Ganis; P R Libby; R J Bergeron
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

5.  Structural specificity of polyamines and polyamine analogues in the protection of DNA from strand breaks induced by reactive oxygen species.

Authors:  H C Ha; J D Yager; P A Woster; R A Casero
Journal:  Biochem Biophys Res Commun       Date:  1998-03-06       Impact factor: 3.575

6.  Rapid induction of apoptosis by deregulated uptake of polyamine analogues.

Authors:  R H Hu; A E Pegg
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

7.  Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer.

Authors:  Judith Hurley; Philomena Doliny; Isildinha Reis; Orlando Silva; Carmen Gomez-Fernandez; Pedro Velez; Giovanni Pauletti; Jodeen E Powell; Mark D Pegram; Dennis J Slamon
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

Review 8.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

9.  Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase.

Authors:  A J Bitonti; T L Byers; T L Bush; P J Casara; C J Bacchi; A B Clarkson; P P McCann; A Sjoerdsma
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

10.  Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas.

Authors:  Jason A Zell; Daniel Pelot; Wen-Pin Chen; Christine E McLaren; Eugene W Gerner; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-03
View more
  35 in total

1.  Novel Pt(II) and Pd(II) complexes with polyamine analogues: synthesis and vibrational analysis.

Authors:  T M Silva; S Oredsson; L Persson; P Woster; M P M Marques
Journal:  J Inorg Biochem       Date:  2011-12-03       Impact factor: 4.155

Review 2.  Recent advances in the molecular biology of metazoan polyamine transport.

Authors:  R Poulin; R A Casero; D Soulet
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

Review 3.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

4.  Use of polyamine derivatives as selective histone deacetylase inhibitors.

Authors:  Patrick M Woster
Journal:  Methods Mol Biol       Date:  2011

5.  Discovery of novel alkylated (bis)urea and (bis)thiourea polyamine analogues with potent antimalarial activities.

Authors:  Bianca K Verlinden; Jandeli Niemand; Janette Snyman; Shiv K Sharma; Ross J Beattie; Patrick M Woster; Lyn-Marie Birkholtz
Journal:  J Med Chem       Date:  2011-09-14       Impact factor: 7.446

Review 6.  Polyamines and cancer: implications for chemotherapy and chemoprevention.

Authors:  Shannon L Nowotarski; Patrick M Woster; Robert A Casero
Journal:  Expert Rev Mol Med       Date:  2013-02-22       Impact factor: 5.600

7.  Targeting the aryl hydrocarbon receptor/polyamine biosynthesis axis of evil for cancer therapy.

Authors:  Robert A Casero
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

8.  Mechanistic and structural analyses of the roles of active site residues in yeast polyamine oxidase Fms1: characterization of the N195A and D94N enzymes.

Authors:  Mariya S Adachi; Alexander B Taylor; P John Hart; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2012-10-15       Impact factor: 3.162

9.  Conjugation with polyamines enhances the antibacterial and anticancer activity of chloramphenicol.

Authors:  Ourania N Kostopoulou; Ekaterini C Kouvela; George E Magoulas; Thomas Garnelis; Ioannis Panagoulias; Maria Rodi; Georgios Papadopoulos; Athanasia Mouzaki; George P Dinos; Dionissios Papaioannou; Dimitrios L Kalpaxis
Journal:  Nucleic Acids Res       Date:  2014-06-17       Impact factor: 16.971

10.  A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047.

Authors:  Wen-Lin Kuo; Debopriya Das; Safiyyah Ziyad; Sanchita Bhattacharya; William J Gibb; Laura M Heiser; Anguraj Sadanandam; Gerald V Fontenay; Zhi Hu; Nicholas J Wang; Nora Bayani; Heidi S Feiler; Richard M Neve; Andrew J Wyrobek; Paul T Spellman; Laurence J Marton; Joe W Gray
Journal:  BMC Med       Date:  2009-12-14       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.